Burroughs Amy L. Insider Trades

Insider Trading History

Track insider trading activity for Burroughs Amy L.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tenaya Therapeutics
Tenaya Therapeutics TNYA
Director
Holding Value $87.1k 120,000 shares
Last Trade
May 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$96k 120,000 shares
$0.80
$0.73
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
May 05, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$141M 2,655,534 shares
$52.97
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
May 05, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$441k 8,319 shares
$53.00
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $50.6M 955,534 shares
Last Trade
Mar 16, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$672k 14,583 shares
$46.07
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $16.1M 303,559 shares
Last Trade
Mar 16, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$672k 14,583 shares
$46.07
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $15.4M 291,746 shares
Last Trade
Mar 16, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$681k 14,583 shares
$46.71
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $16.1M 303,559 shares
Last Trade
Feb 17, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$577k 14,583 shares
$39.58
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $51.4M 970,117 shares
Last Trade
Feb 17, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$577k 14,583 shares
$39.58
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $15.9M 301,218 shares
Last Trade
Feb 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$572k 14,583 shares
$39.20
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $18.9M 357,725 shares
Last Trade
Jan 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.54M 68,749 shares
$36.98
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $15.7M 296,497 shares
Last Trade
Jan 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.55M 68,749 shares
$37.08
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $54.3M 1,026,366 shares
Last Trade
Jan 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.54M 68,749 shares
$36.98
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $15.9M 300,000 shares
Last Trade
Jan 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.7M 450,000 shares
$37.18
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Jan 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.88M 150,000 shares
$39.19
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $11.1M 210,315 shares
Last Trade
Jan 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.88M 150,000 shares
$39.19
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $7.36M 138,976 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.72M 71,339 shares
$38.10
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $55.8M 1,053,449 shares
Last Trade
Jan 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$864k 21,551 shares
$40.11
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $3.19M 60,315 shares
Last Trade
Jan 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$864k 21,551 shares
$40.11
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Chief Executive Officer
Holding Value $2.49M 47,083 shares
Last Trade
Jun 25, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$90.2k 23,314 shares
$3.87
$52.95
Tenaya Therapeutics
Tenaya Therapeutics TNYA
Director
Holding Value $78k 107,400 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.3k 107,400 shares
$0.44
$0.73

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up